In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method

被引:46
作者
Taj-Aldeen, Saad J. [1 ,2 ]
Salah, Husam [1 ,3 ]
Al-Hatmi, Abdullah M. S. [3 ,4 ,5 ]
Hamed, Manal [1 ]
Theelen, Bart [3 ]
van Diepeningen, Anne D. [3 ]
Boekhout, Teun [3 ,6 ,7 ]
Lass-Floerl, Cornelia [8 ]
机构
[1] Hamad Med Corp, Div Microbiol, Dept Lab Med & Pathol, POB 3050, Doha, Qatar
[2] Weill Cornell Med Coll, Doha, Qatar
[3] CBS KNAW Fungal Biodivers Ctr, Utrecht, Netherlands
[4] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands
[5] Ibri Hosp, Minist Hlth, Directorate Gen Hlth Serv, Ibri, Oman
[6] Second Mil Med Univ, Changzheng Hosp, Inst Dermatol & Med Mycol, Dept Dermatol,Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China
[7] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China
[8] Med Univ Innsbruck, Div Hyg & Med Microbiol, Innsbruck, Austria
关键词
Fusarium; EUCAST antifungal susceptibility; Amphotericin B; Triazoles; Resistance; CELL TRANSPLANT RECIPIENTS; INVASIVE FUSARIOSIS; PHYLOGENETIC DIVERSITY; FUNGAL-INFECTIONS; COMPLEX; DISEASES; SOLANI; SPP; LEUKEMIA; AGENTS;
D O I
10.1016/j.diagmicrobio.2016.05.006
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Susceptibility testing using the EUCAST-AFST method against 39 clinical Fusarium strains consecutively collected from local and invasive infections during the last 10 years assessed the in vitro activities of amphotericin B (AmB) and triazole antifungal agents. In addition, the susceptibility pattern of 12 reference strains from the CBS-KNAW Fungal Biodiversity Centre (CBS) was evaluated. In particular Fusarium petroliphilum and F. solani sensu lato were involved in disseminated infections and known for treatment failure. AmB displayed the lowest MICs followed by voriconazole VRC, posaconazole (POC). Itraconazole (ITC) showed high MIC values, displaying in vitro resistance. Clinical isolates were significantly (P < 0.05) more resistant to AmB, VRC, and POC, than the CBS reference isolates probably due to previous exposure to antifungal therapy. Resistant profiles to AmB and VRC, which are the currently recommended agents in the guidelines for treatments, and a late diagnosis may be associated with high mortality rate in immunocompromised patients. The present antifungal susceptibility profiles showed that species- and strain-specific differences in antifungal susceptibility exist within Fusarium and that susceptibility testing is important and may improve the prognosis of these infections. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:438 / 443
页数:6
相关论文
共 36 条
[1]   Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex [J].
Al-Hatmi, Abdullah M. S. ;
van Diepeningen, Anne D. ;
Curfs-Breuker, Ilse ;
de Hoog, G. Sybren ;
Meis, Jacques F. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (04) :1068-1071
[2]   Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods [J].
Alastruey-Izquierdo, Ana ;
Cuenca-Estrella, Manuel ;
Monzon, Araceli ;
Mellado, Emilia ;
Luis Rodriguez-Tudela, Juan .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (04) :805-809
[3]   Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification [J].
Araujo, R. ;
Oliveira, M. ;
Amorim, A. ;
Sampaio-Maia, B. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (07) :1289-1301
[4]   In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F-moniliforme) and Fusarium thapsinum [J].
Azor, Monica ;
Gene, Josepa ;
Cano, Josep ;
Sutton, Deanna A. ;
Fothergill, Annette W. ;
Rinaldi, Michael G. ;
Guarrol, Josep .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) :2228-2231
[5]   Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex [J].
Azor, Monica ;
Gene, Josepa ;
Cano, Josep ;
Guarro, Josep .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) :1500-1503
[6]   Skin lesions associated with Fusarium infection [J].
Bodey, GP ;
Boktour, M ;
Mays, S ;
Duvic, M ;
Kontoyiannis, D ;
Hachem, R ;
Raad, I .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (05) :659-666
[7]   Disseminated Fusariosis Occurring in Two Patients Despite Posaconazole Prophylaxis [J].
Bose, Prithviraj ;
Parekh, Hiral D. ;
Holter, Jennifer L. ;
Greenfield, Ronald A. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (04) :1674-1675
[8]   Geographic differences in trichothecene chemotypes of Fusarium graminearum in the Northwest and North of Iran [J].
Davari, M. ;
Wei, S. H. ;
Babay-Ahari, A. ;
Arzanlou, M. ;
Waalwijk, C. ;
van der Lee, T. A. J. ;
Zare, R. ;
van den Ende, A. H. G. Gerrits ;
de Hoog, G. S. ;
van Diepeningen, A. D. .
WORLD MYCOTOXIN JOURNAL, 2013, 6 (02) :137-150
[9]   Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group [J].
De Pauw, Ben ;
Walsh, Thomas J. ;
Donnelly, J. Peter ;
Stevens, David A. ;
Edwards, John E. ;
Calandra, Thierry ;
Pappas, Peter G. ;
Maertens, Johan ;
Lortholary, Olivier ;
Kauffman, Carol A. ;
Denning, David W. ;
Patterson, Thomas F. ;
Maschmeyer, Georg ;
Bille, Jacques ;
Dismukes, William E. ;
Herbrecht, Raoul ;
Hope, William W. ;
Kibbler, Christopher C. ;
Kullberg, Bart Jan ;
Marr, Kieren A. ;
Munoz, Patricia ;
Odds, Frank C. ;
Perfect, John R. ;
Restrepo, Angela ;
Ruhnke, Markus ;
Segal, Brahm H. ;
Sobel, Jack D. ;
Sorrell, Tania C. ;
Viscoli, Claudio ;
Wingard, John R. ;
Zaoutis, Theoklis ;
Bennett, John E. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) :1813-1821
[10]   International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method [J].
Espinel-Ingroff, A. ;
Colombo, A. L. ;
Cordoba, S. ;
Dufresne, P. J. ;
Fuller, J. ;
Ghannoum, M. ;
Gonzalez, G. M. ;
Guarro, J. ;
Kidd, S. E. ;
Meis, J. F. ;
Melhem, T. M. S. C. ;
Pelaez, T. ;
Pfaller, M. A. ;
Szeszs, M. W. ;
Takahaschi, J. P. ;
Tortorano, A. M. ;
Wiederhold, N. P. ;
Turnidger, J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (02) :1079-1084